Three charities have united with actor Stephen Fry, who survived PCa, to call for precision treatments Olaparib and Pluvicto to be made available. See more here
- Newsletter
We are to email two newsletters a year to members in future. David Casley, Prospect Publicity 07860 369064; Email prospect.bristol@gmail.com
News
The overall cancer death rate has fallen 16pc since Cancer Research UK was founded, the charity said. It added that about 310 in every 100,000 people died from cancer each year in the UK in the early 2000s – but that now it’s around 260. See more here
A cancer vaccine that uses the same technology as Covid shots has been shown to slash the risk of tumours returning in advanced melanoma patients. More here
New research shows a third of men are putting off doing PCa checks, which have the potential to be life saving. More here
Researchers are a step closer to understanding how PCa begins. This finding could make it possible to find which men are at greatest risk and design treatments to prevent the cancer. It also suggests that, in men who already have the disease, it may be better to treat the whole prostate rather than only the areas that have cancer. More here
Potential cancer breakthrough as scientists finally discover how tumours ‘hijack’ healthy cells. See here
The Prostate Cancer Research Pod is back with new episodes! Host Ben Monro-Davies chats to the people behind the research – from those living with PCa to the scientists working to find new treatments. Join here
Public health messaging around PCa places a misleading focus on urinary symptoms and may be hampering efforts of early detection, scientists have warned. Researchers said there was “no evidence of a causal link between PCa and either prostate size or troublesome urinary symptoms”. But public health guidance regularly promotes this link. Worried about PCa? Check here in 30 seconds
Scientists have early evidence that one way to kill recurring cancer cells may be with a lot of iron. More here
People with a worrying cough, problems swallowing or blood in their urine will soon be able to be referred for scans and checks by a pharmacist, rather than by their GP. A new pilot scheme, in England, aims to diagnose more cancers early, when there is a better chance of a cure. The NHS also plans to offer Jewish people genetic screening – as up to one in 40 has Brca mutations, linked to a higher risk of breast, ovarian and prostate cancers, compared with one in 400 in the general population.